Figure 5
The Treg/Th17 balance. The ratio of Treg : Th17 cells was measured pre- (white), during (grey), and post (black)-trastuzumab therapy in early breast cancer (EBC) and metastatic breast cancer (MBC) patients. The third histogram shows the relative ratios seen in healthy and HER2− controls. The number of Treg cells to every Th17 cell is shown. Error bars represent ±s.e. P-values <0.05, as measured by the Mann–Whitney U-test, were considered significant.
